Cyclin dependent kinase 2 and the regulation of human progesterone receptor activity

Steroids

Volumn 72, Issue 2, 2007, Pages 202-209

  Moore, Nicole L ^a   Narayanan, Ramesh ^a   Weigel, Nancy L ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cdk2; Cyclin A; Kinase; Phosphorylation; Progesterone receptor

Indexed keywords

CYCLIN A; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; PHOSPHATASE; PHOSPHOPROTEIN; PROGESTERONE RECEPTOR; PROTEIN P160; STEROID RECEPTOR COACTIVATOR 1;

ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

CYCLIN-DEPENDENT KINASE 2; GENE EXPRESSION REGULATION; HUMANS; RECEPTORS, PROGESTERONE; SIGNAL TRANSDUCTION;

EID: 33847066362     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2006.11.025     Document Type: Article

References (75)

1. Graham J.D., and Clarke C.L. Physiological action of progesterone in target tissues. Endocr Rev 18 (1997) 502-519
2. Conneely O.M., Mulac-Jericevic B., and Lydon J.P. Progesterone-dependent regulation of female reproductive activity by two distinct progesterone receptor isoforms. Steroids 68 (2003) 771-778
3. Horwitz K.B., and Alexander P.S. In situ photolinked nuclear progesterone receptors of human breast cancer cells: subunit molecular weights after transformation and translocation. Endocrinology 113 (1983) 2195-2201
4. Kastner P., Krust A., Turcotte B., Stropp U., Tora L., Gronemeyer H., et al. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J 9 (1990) 1603-1614
5. Meyer M.E., Quirin-Stricker C., Lerouge T., Bocquel M.T., and Gronemeyer H. A limiting factor mediates the differential activation of promoters by the human progesterone receptor isoforms. J Biol Chem 267 (1992) 10882-10887
6. Vegeto E., Shahbaz M.M., Wen D.X., Goldman M.E., O'Malley B.W., and McDonnell D.P. Human progesterone receptor A form is a cell-and promoter-specific repressor of human progesterone receptor B function. Mol Endocrinol 7 (1993) 1244-1255
7. McDonnell D.P., Shahbaz M.M., Vegeto E., and Goldman M.E. The human progesterone receptor A-form functions as a transcriptional modulator of mineralocorticoid receptor transcriptional activity. J Steroid Biochem Mol Biol 48 (1994) 425-432
8. Richer J.K., Jacobsen B.M., Manning N.G., Abel M.G., Wolf D.M., and Horwitz K.B. Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J Biol Chem 277 (2002) 5209-5218
9. Mulac-Jericevic B., Mullinax R.A., DeMayo F.J., Lydon J.P., and Conneely O.M. Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform. Science 289 (2000) 1751-1754
10. Mulac-Jericevic B., Lydon J.P., DeMayo F.J., and Conneely O.M. Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform. Proc Natl Acad Sci USA 100 (2003) 9744-9749
11. Sartorius C.A., Melville M.Y., Hovland A.R., Tung L., Takimoto G.S., and Horwitz K.B. A third transactivation function (AF3) of human progesterone receptors located in the unique N-terminal segment of the B-isoform. Mol Endocrinol 8 (1994) 1347-1360
12. Tsai M.J., and O'Malley B.W. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 63 (1994) 451-486
13. Aranda A., and Pascual A. Nuclear hormone receptors and gene expression. Physiol Rev 81 (2001) 1269-1304
14. Rosenfeld J.M., Kao H.Y., and Evans R.M. The nuclear receptor superfamily. In: Henderson B.E., Ponder B., and Ross R.K. (Eds). Hormones, genes and cancer (2003), Oxford University Press, New York 38-98
15. Bamberger A.M., Bamberger C.M., Gellersen B., and Schulte H.M. Modulation of AP-1 activity by the human progesterone receptor in endometrial adenocarcinoma cells. Proc Natl Acad Sci USA 93 (1996) 6169-6174
16. Owen G.I., Richer J.K., Tung L., Takimoto G., and Horwitz K.B. Progesterone regulates transcription of the p21(WAF1) cyclin-dependent kinase inhibitor gene through Sp1 and CBP/p300. J Biol Chem 273 (1998) 10696-10701
17. Gao J., Mazella J., Seppala M., and Tseng L. Ligand activated hPR modulates the glycodelin promoter activity through the Sp1 sites in human endometrial adenocarcinoma cells. Mol Cell Endocrinol 176 (2001) 97-102
18. Tseng L., Tang M., Wang Z., and Mazella J. Progesterone receptor (hPR) upregulates the fibronectin promoter activity in human decidual fibroblasts. DNA Cell Biol 22 (2003) 633-640
19. Tang M., Mazella J., Gao J., and Tseng L. Progesterone receptor activates its promoter activity in human endometrial stromal cells. Mol Cell Endocrinol 192 (2002) 45-53
20. Gizard F., Robillard R., Gross B., Barbier O., Revillion F., Peyrat J.P., et al. TReP-132 is a novel progesterone receptor coactivator required for the inhibition of breast cancer cell growth and enhancement of differentiation by progesterone. Mol Cell Biol 26 (2006) 7632-7644
21. Weigel N.L. Steroid hormone receptors and their regulation by phosphorylation. Biochem J 319 (1996) 657-667
22. Knotts T.A., Orkiszewski R.S., Cook R.G., Edwards D.P., and Weigel N.L. Identification of a phosphorylation site in the hinge region of the human progesterone receptor and additional amino-terminal phosphorylation sites. J Biol Chem 276 (2001) 8475-8483
23. Rowan B.G., Garrison N., Weigel N.L., and O'Malley B.W. 8-Bromo-cyclic AMP induces phosphorylation of two sites in SRC-1 that facilitate ligand-independent activation of the chicken progesterone receptor and are critical for functional cooperation between SRC-1 and CREB binding protein. Mol Cell Biol 20 (2000) 8720-8730
24. Rowan B.G., Weigel N.L., and O'Malley B.W. Phosphorylation of steroid receptor coactivator-1. Identification of the phosphorylation sites and phosphorylation through the mitogen-activated protein kinase pathway. J Biol Chem 275 (2000) 4475-4483
25. Wu R.C., Qin J., Yi P., Wong J., Tsai S.Y., Tsai M.J., et al. Selective phosphorylations of the SRC-3/AIB1 coactivator integrate genomic reponses to multiple cellular signaling pathways. Mol Cell 15 (2004) 937-949
26. Wu R.C., Smith C.L., and O'Malley B.W. Transcriptional regulation by steroid receptor coactivator phosphorylation. Endocr Rev 26 (2005) 393-399
27. Narayanan R., Adigun A.A., Edwards D.P., and Weigel N.L. Cyclin-dependent kinase activity is required for progesterone receptor function: novel role for cyclin A/Cdk2 as a progesterone receptor coactivator. Mol Cell Biol 25 (2005) 264-277
28. Qiu M., and Lange C.A. MAP kinases couple multiple functions of human progesterone receptors: degradation, transcriptional synergy, and nuclear association. J Steroid Biochem Mol Biol 85 (2003) 147-157
29. Shen T., Horwitz K.B., and Lange C.A. Transcriptional hyperactivity of human progesterone receptors is coupled to their ligand-dependent down-regulation by mitogen-activated protein kinase-dependent phosphorylation of serine 294. Mol Cell Biol 21 (2001) 6122-6131
30. Weigel N.L., and Zhang Y. Ligand-independent activation of steroid hormone receptors. J Mol Med 76 (1998) 469-479
31. Edwards D.P., Weigel N.L., Nordeen S.K., and Beck C.A. Modulators of cellular protein phosphorylation alter the trans-activation function of human progesterone receptor and the biological activity of progesterone antagonists. Breast Cancer Res Treat 27 (1993) 41-56
32. Beck C.A., Weigel N.L., and Edwards D.P. Effects of hormone and cellular modulators of protein phosphorylation on transcriptional activity, DNA binding, and phosphorylation of human progesterone receptors. Mol Endocrinol 6 (1992) 607-620
33. Pierson-Mullany L.K., and Lange C.A. Phosphorylation of progesterone receptor serine 400 mediates ligand-independent transcriptional activity in response to activation of cyclin-dependent protein kinase 2. Mol Cell Biol 24 (2004) 10542-10557
34. Labriola L., Salatino M., Proietti C.J., Pecci A., Coso O.A., Kornblihtt A.R., et al. Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells. Mol Cell Biol 23 (2003) 1095-1111
35. Kazmi S.M., Visconti V., Plante R.K., Ishaque A., and Lau C. Differential regulation of human progesterone receptor A and B form-mediated trans-activation by phosphorylation. Endocrinology 133 (1993) 1230-1238
36. Boonyaratanakornkit V., and Edwards D.P. Receptor mechanisms of rapid extranuclear signalling initiated by steroid hormones. Essays Biochem 40 (2004) 105-120
37. Watson C.S., and Lange C.A. Steadying the boat: integrating mechanisms of membrane and nuclear-steroid-receptor signalling. EMBO Rep 6 (2005) 116-119
38. Weigel N.L., Bai W., Zhang Y., Beck C.A., Edwards D.P., and Poletti A. Phosphorylation and progesterone receptor function. J Steroid Biochem Mol Biol 53 (1995) 509-514
39. Lange C.A. Making sense of cross-talk between steroid hormone receptors and intracellular signaling pathways: who will have the last word?. Mol Endocrinol 18 (2004) 269-278
40. Biondi R.M., and Nebreda A.R. Signalling specificity of Ser/Thr protein kinases through docking-site-mediated interactions. Biochem J 372 (2003) 1-13
41. Zhang Y., Beck C.A., Poletti A., Edwards D.P., and Weigel N.L. Identification of a group of Ser-Pro motif hormone-inducible phosphorylation sites in the human progesterone receptor. Mol Endocrinol 9 (1995) 1029-1040
42. Takimoto G.S., Tasset D.M., Eppert A.C., and Horwitz K.B. Hormone-induced progesterone receptor phosphorylation consists of sequential DNA-independent and DNA-dependent stages: analysis with zinc finger mutants and the progesterone antagonist ZK98299. Proc Natl Acad Sci USA 89 (1992) 3050-3054
43. Zhang Y., Beck C.A., Poletti A., Edwards D.P., and Weigel N.L. Identification of phosphorylation sites unique to the B form of human progesterone receptor In vitro phosphorylation by casein kinase II. J Biol Chem 269 (1994) 31034-31040
44. Zhang Y., Beck C.A., Poletti A., Clement J.P., Prendergast P., Yip T.T., et al. Phosphorylation of human progesterone receptor by cyclin-dependent kinase 2 on three sites that are authentic basal phosphorylation sites in vivo. Mol Endocrinol 11 (1997) 823-832
45. Beck C.A., Zhang Y., Altmann M., Weigel N.L., and Edwards D.P. Stoichiometry and site-specific phosphorylation of human progesterone receptor in native target cells and in the baculovirus expression system. J Biol Chem 271 (1996) 19546-19555
46. Lange C.A., Shen T., and Horwitz K.B. Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome. Proc Natl Acad Sci USA 97 (2000) 1032-1037
47. Narayanan R., Edwards D.P., and Weigel N.L. Human progesterone receptor displays cell cycle-dependent changes in transcriptional activity. Mol Cell Biol 25 (2005) 2885-2898
48. Yam C.H., Fung T.K., Poon R.Y., and Cyclin. A in cell cycle control and cancer. Cell Mol Life Sci 59 (2002) 1317-1326
49. Murphy M., Stinnakre M.G., Senamaud-Beaufort C., Winston N.J., Sweeney C., Kubelka M., et al. Delayed early embryonic lethality following disruption of the murine cyclin A2 gene. Nat Genet 15 (1997) 83-86
50. Ortega S., Prieto I., Odajima J., Martin A., Dubus P., Sotillo R., et al. Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice. Nat Genet 35 (2003) 25-31
51. Berthet C., Aleem E., Coppola V., Tessarollo L., and Kaldis P. Cdk2 knockout mice are viable. Curr Biol 13 (2003) 1775-1785
52. Fung T.K., and Poon R.Y. A roller coaster ride with the mitotic cyclins. Semin Cell Dev Biol 16 (2005) 335-342
53. Morgan D.O. Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu Rev Cell Dev Biol 13 (1997) 261-291
54. Clemm D.L., Sherman L., Boonyaratanakornkit V., Schrader W.T., Weigel N.L., and Edwards D.P. Differential hormone-dependent phosphorylation of progesterone receptor A and B forms revealed by a phosphoserine site-specific monoclonal antibody. Mol Endocrinol 14 (2000) 52-65
55. Takimoto G.S., Hovland A.R., Tasset D.M., Melville M.Y., Tung L., and Horwitz K.B. Role of phosphorylation on DNA binding and transcriptional functions of human progesterone receptors. J Biol Chem 271 (1996) 13308-13316
56. Faivre E., Skildum A., Pierson-Mullany L., and Lange C.A. Integration of progesterone receptor mediated rapid signaling and nuclear actions in breast cancer cell models: role of mitogen-activated protein kinases and cell cycle regulators. Steroids 70 (2005) 418-426
57. Nardulli A.M., and Katzenellenbogen B.S. Progesterone receptor regulation in T47D human breast cancer cells: analysis by density labeling of progesterone receptor synthesis and degradation and their modulation by progestin. Endocrinology 122 (1988) 1532-1540
58. Glotzer M., Murray A.W., and Kirschner M.W. Cyclin is degraded by the ubiquitin pathway. Nature 349 (1991) 132-138
59. King R.W., Glotzer M., and Kirschner M.W. Mutagenic analysis of the destruction signal of mitotic cyclins and structural characterization of ubiquitinated intermediates. Mol Biol Cell 7 (1996) 1343-1357
60. Bhattacharjee R.N., Banks G.C., Trotter K.W., Lee H.L., and Archer T.K. Histone H1 phosphorylation by Cdk2 selectively modulates mouse mammary tumor virus transcription through chromatin remodeling. Mol Cell Biol 21 (2001) 5417-5425
61. Redeuilh G., Attia A., Mester J., and Sabbah M. Transcriptional activation by the oestrogen receptor alpha is modulated through inhibition of cyclin-dependent kinases. Oncogene 21 (2002) 5773-5782
62. Trowbridge J.M., Rogatsky I., and Garabedian M.J. Regulation of estrogen receptor transcriptional enhancement by the cyclin A/Cdk2 complex. Proc Natl Acad Sci USA 94 (1997) 10132-10137
63. Rogatsky I., Trowbridge J.M., and Garabedian M.J. Potentiation of human estrogen receptor alpha transcriptional activation through phosphorylation of serines 104 and 106 by the cyclin A-CDK2 complex. J Biol Chem 274 (1999) 22296-22302
64. Krstic M.D., Rogatsky I., Yamamoto K.R., and Garabedian M.J. Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor. Mol Cell Biol 17 (1997) 3947-3954
65. Almlof T., Wright A.P., and Gustafsson J.A. Role of acidic and phosphorylated residues in gene activation by the glucocorticoid receptor. J Biol Chem 270 (1995) 17535-17540
66. Mason S.A., and Housley P.R. Site-directed mutagenesis of the phosphorylation sites in the mouse glucocorticoid receptor. J Biol Chem 268 (1993) 21501-21504
67. Webster J.C., Jewell C.M., Bodwell J.E., Munck A., Sar M., and Cidlowski J.A. Mouse glucocorticoid receptor phosphorylation status influences multiple functions of the receptor protein. J Biol Chem 272 (1997) 9287-9293
68. Senderowicz A.M. Small-molecule cyclin-dependent kinase modulators. Oncogene 22 (2003) 6609-6620
69. Meijer L., and Raymond E. Roscovitine and other purines as kinase inhibitors. From starfish oocytes to clinical trials. Acc Chem Res 36 (2003) 417-425
70. Beck C.A., Weigel N.L., Moyer M.L., Nordeen S.K., and Edwards D.P. The progesterone antagonist RU486 acquires agonist activity upon stimulation of cAMP signaling pathways. Proc Natl Acad Sci USA 90 (1993) 4441-4445
71. Sartorius C.A., Tung L., Takimoto G.S., and Horwitz K.B. Antagonist-occupied human progesterone receptors bound to DNA are functionally switched to transcriptional agonists by cAMP. J Biol Chem 268 (1993) 9262-9266
72. Sartorius C.A., Groshong S.D., Miller L.A., Powell R.L., Tung L., Takimoto G.S., et al. New T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP. Cancer Res 54 (1994) 3868-3877
73. Groshong S.D., Owen G.I., Grimison B., Schauer I.E., Todd M.C., Langan T.A., et al. Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1). Mol Endocrinol 11 (1997) 1593-1607
74. Musgrove E.A., Swarbrick A., Lee C.S., Cornish A.L., and Sutherland R.L. Mechanisms of cyclin-dependent kinase inactivation by progestins. Mol Cell Biol 18 (1998) 1812-1825
75. Qiu M., Olsen A., Faivre E., Horwitz K.B., and Lange C.A. Mitogen-activated protein kinase regulates nuclear association of human progesterone receptors. Mol Endocrinol 17 (2003) 628-642